Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Proteasome inhibitors show potential in inflammatory disorders

Feb. 2, 1999

Selective COX-2 inhibitors evaluated for antiinflammatory and analgesic effects at Grelan

Feb. 1, 1999

Abgenix initiates phase I trial with ABX-IL-8 in rheumatoid arthritis patients

Jan. 29, 1999

Medarex's first HuMAb-Mouse-derived antibody enters the clinic

Jan. 29, 1999

Cytokine inhibitors from Merck presented in recent patent literature

Jan. 29, 1999

Dietary therapy of rheumatoid arthritis evaluated in six-month controlled trial

Jan. 28, 1999

Licensing opportunity from NIH: methods of treating inflammation

Jan. 28, 1999

UPSA reveals potent, orally active and well-tolerated antiinflammatory/analgesic agents

Jan. 28, 1999

Novel triptolide derivatives from HMR for rheumatoid arthritis and other autoimmune diseases

Jan. 28, 1999

Centocor files sBLA for infliximab in RA indication

Jan. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...